DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $197,586 | -20.4% | 22,052 | 0.0% | 0.00% | – |
| Q2 2023 | $248,085 | -83.7% | 22,052 | -83.3% | 0.00% | -100.0% |
| Q1 2023 | $1,524,603 | +496.5% | 132,344 | +500.1% | 0.00% | +200.0% |
| Q4 2022 | $255,583 | -69.0% | 22,052 | -66.0% | 0.00% | -50.0% |
| Q3 2022 | $824,000 | -65.7% | 64,910 | -81.4% | 0.00% | -60.0% |
| Q2 2022 | $2,400,000 | -28.7% | 349,279 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $3,367,000 | -18.9% | 349,279 | 0.0% | 0.01% | -25.0% |
| Q4 2021 | $4,154,000 | +1060.3% | 349,279 | +1483.9% | 0.01% | +700.0% |
| Q3 2021 | $358,000 | -22.8% | 22,052 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $464,000 | – | 22,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |